MEDTRONIC, INC. (MDT).
Term Paper ID:29436
|
|
|
Essay Subject:
Financial ratio analysis of the company.... More...
|
5 Pages / 1125 Words
5 sources, 5 Citations,
APA Format
$40.00
Return to List of Papers
|
Paper Abstract:
Financial ratio analysis of the company. Company structure of four business units that manufacture medical devices to treat chronic diseases. News summaries of Medtronic's EPS. Company earnings and revenues. Human resource expenditures. Standard & Poors outlook of company. Two charts of Wall Street listings. Trends.
Paper Introduction:
Financial Ratio Analysis: Medtronic, Inc. (MDT)
Company Description
Medtronic, Inc. is a medical device manufacturer that provides treatment solutions for chronic disease. The company is structured into four business units: Cardiac Rhythm Management; Vascular; Cardiac Surgery; and Neurological, Spinal and ENT. In August 2001 Medtronic also acquired two companies, MiniMed Inc. and Medical Research Group, Inc., which will form Medtronic MiniMed. That company will provide diabetic treatment solutions.
News Summaries
UBS Warbu
Text of the Paper:
The entire text of the paper is shown below. However, the text is somewhat scrambled. We want to give you as much information as we possibly can about our papers and essays, but we cannot give them away for free. In the text below you will find that while disordered, many of the phrases are essentially intact. From this text you will be able to get a solid sense of the writing style, the concepts addressed, and the sources used in the research paper.
Management Vascular Cardiac Surgery and Neurological Spinal and Upbeat on Medtronic Business Week Analyst was lower than expected but remained strong on the position despite lowering hisprice target due will allow doctors and patients with to Medtronic's internal computers Doctorsand patients can initially be used on patients with defibrillators but Medtronic revenuesfor Medtronics The business base product the growth rate to All four business General Research Group Inc moving the company these efforts over thelast two years Future growth to having completed clinical testingand awaiting FDA revue In addition acknowledgement that the company relies heavily on the skills rate of to for fiscalyear This would be the positive impact the recent acquisition of MiniMed and from costs associated with increased R D Nonetheless S Pestimates P points out that morefavorable tax in Wall Street Journal Listing YTD Wk Stock SYM Bil BilCompany SIC Company Ratios Industry Av acquisition and mergers and increased R remain highly liquid Earnings too have been strong continued introduction ofnew devices across all of its has continued to spurmarket estimates to maintain strong buy recommendations some impact on Medtronic stock into thenext fiscal businessweek com Financial Times Jan Medtronic wins for chronic disease The company which willform Medtronic MiniMed That company will it's consensusEPS for the quarter for sales as new technologies were due Financial Times Medtronic has received devices with a small antenna that the patient's internal devise isrequired to annual report was the th diluted share Earnings per diluted share were afternon-recurring pre-tax to gain a leadership position in every major market has been a main focus of business areas in which the companyoperates The market readiness of in increasedearnings Medtronic increased its set to move ahead Comparison of Medtronic Outlook that revenues will be aidedby the introduction result from recent acquisitions The company also fails to in that value to This is in line with Medtronic'sown the introduction of newproducts across its operating markets price ytd Total Book value Assets liabilities preferred stock Bil Financial Analysis Trends Medtronic has shown a continued increase in value of the company The absence unit The negative impact of thatincident has been seems to be its R D efforts The introduction ofnew company isstill recouping from a costly recall a cardiac devise Financials Medtronic Inc Business Week May Financial Ratio Analysis Medtronic Inc MDT Company Description Medtronic ENT In August Medtronic also acquiredtwo companies David Lothson lowered his estimate on Medtronic's EPS stock According to Lothson the last two quarters to the slow sales and negative implanted cardiacdevices to review their condition via then log onto the Internet to review plans to extend the use to other internal cardiac line and economic reachcontinued to expand as unitsreported record earnings and revenues in A commitment into thediabetic treatment industry In addition R D expenditures rose is promising for Medtronic as new devices Medtronic's move into the diabetictreatment industry andexpertise of its employees Finally the company came through a slow down from the rate of noted inthe Annual GeneralResearch should have The company however fails to mention the net EPS for to be rates account for at least a part of YLD Vol Last Net Chg hi lo Short-term Solvency Current ratio Quick ratio Long-term Solvency D This has for the Hampered only by recent problems with a business units as well as a move into Weaknesses Medtronics appears to be year References Medtronic Inc Annual Report Medtronic Inc FDA Backing Online Available http www ft com is structured intofour business units Cardiac Rhythm provide diabetic treatmentsolutions News SummariesUBS Warburg Remains Q Lothson reasoned that sales growth of only to beintroduced He reiterated his strong buy FDA approval for its CareLink monitoringsystem The system will then transfer theinformation via telephone line use the CareLink monitor The system will consecutive year of increased earnings and charges Revenue rose with foreign exchangetranslation reducing inwhich the company participates continued in Medtronic acquiredMiniMed Inc and R D Roughly two-thirds of revenue was a result of these introductions range from beingunder consideration for FDA approval expenditure on Human Resources over the year an with S P Outlook Standard and Poors expects a growth of new technologies across Medtronic's operations aswell as mention the narrowing of margins that haveresulted forecast for future earning growth though S will result in increasing sales andearnings growth Bil BilTotal Market value outstanding shares price trend of growth and expansion boththrough ofdebt has also allowed the company to more than made up for through technologies across all of its business units Analysts appear tosee that incident having at least UBS Warburg Remains Upbeat onMedtronic Online Available http Inc is a medical device manufacturer that providestreatment solutions MiniMed Inc and Medical Research Group Inc forfiscal from to despite the company hitting of fiscal and fiscal looked promising press regarding thecompany's cardiac unit Medtronic wins FDA Backing Internet The patients will scantheir internal the patient'sinformation No additional adjustment to devises asfurther FDA approval is gained Summary of President's Letter well Pre-charge earnings rose over the previousyear to per over the past several years to introducing innovativedevices in order Innovative work in cardiologic stints are beingintroduced in each of the four through recent mergers promises to result its CEOtransition smoothly and is now report S P agrees with the company the increasedinterest costs that will per diluted share and seescontinued growth that rise Overall S P agrees with the company that Div PE s CHG Medtronic MDT P E ratio Total debt NA ratio Debt-equity ratio mostpart resulted in a steady cardiac devicedistributed through its cardiac business thediabetic treatment industry Strengths Medtronics main strength slightly over-valued In addition the Standard Poor's Jan Medtronic Inc Stock Report McGrawHill Hoover's Company Management Vascular Cardiac Surgery and Neurological Spinal and Upbeat on Medtronic Business Week Analyst was lower than expected but remained strong on the position despite lowering hisprice target due will allow doctors and patients with to Medtronic's internal computers Doctorsand patients can initially be used on patients with defibrillators but Medtronic revenuesfor Medtronics The business base product the growth rate to All four business General Research Group Inc moving the company these efforts over thelast two years Future growth to having completed clinical testingand awaiting FDA revue In addition acknowledgement that the company relies heavily on the skills rate of to for fiscalyear This would be the positive impact the recent acquisition of MiniMed and from costs associated with increased R D Nonetheless S Pestimates P points out that morefavorable tax in Wall Street Journal Listing YTD Wk Stock SYM Bil BilCompany SIC Company Ratios Industry Av acquisition and mergers and increased R remain highly liquid Earnings too have been strong continued introduction ofnew devices across all of its has continued to spurmarket estimates to maintain strong buy recommendations some impact on Medtronic stock into thenext fiscal businessweek com Financial Times Jan Medtronic wins for chronic disease The company which willform Medtronic MiniMed That company will it's consensusEPS for the quarter for sales as new technologies were due Financial Times Medtronic has received devices with a small antenna that the patient's internal devise isrequired to annual report was the th diluted share Earnings per diluted share were afternon-recurring pre-tax to gain a leadership position in every major market has been a main focus of business areas in which the companyoperates The market readiness of in increasedearnings Medtronic increased its set to move ahead Comparison of Medtronic Outlook that revenues will be aidedby the introduction result from recent acquisitions The company also fails to in that value to This is in line with Medtronic'sown the introduction of newproducts across its operating markets price ytd Total Book value Assets liabilities preferred stock Bil Financial Analysis Trends Medtronic has shown a continued increase in value of the company The absence unit The negative impact of thatincident has been seems to be its R D efforts The introduction ofnew company isstill recouping from a costly recall a cardiac devise Financials Medtronic Inc Business Week May
If this paper is not what you are looking for, you can search again:
or
Click here to request an essay written just for you.
|
|
|
